Sio Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Sio Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-48,768	Closed	-$1.56M	–	84
2022 Q1	$1.56M	Sell	48,768 -46,682	-49%	-$1.34M	0.52%	42
2021 Q4	$2.08M	Hold	95,450	–	–	0.63%	41
2021 Q3	$2.09M	Buy	95,450 +2,198	+2%	+$44K	0.67%	41
2021 Q2	$1.82M	Buy	93,252 +12,300	+15%	+$224K	0.45%	59
2021 Q1	$1.4M	Buy	80,952 +14,497	+22%	+$230K	0.28%	75
2020 Q4	$1.06M	Buy	+66,455	New	+$923K	0.22%	79
2020 Q2	–	Sell	-15,395	Closed	-$151K	–	98
2020 Q1	$151K	Buy	+15,395	New	+$202K	0.05%	65

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sio Capital Management's SRRA Position: Q2 2022 in Review

Sio Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 48,768 shares — an estimated $1.56M sold.

Sio Capital Management first reported a position in SRRA in Q1 2020 and held it in 7 quarters. The position peaked at $2.09M in Q3 2021. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

Sio Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Sio Capital Management sold 48,768 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $1.56M.
Sio Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
Sio Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $2.09M in Q3 2021.
109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.